MELCAYA at MPNEconsensus 2024 on Data, AI and data-dependent business models

Melanoma Patient Network Europe (MPNE) is proud to announce the AI, Data, and Data-Dependent Business Models workshop took place in Berlin between 31 January and 2 February 2024 at Fraunhofer & Heinrich Hertz  Institute. The meeting integrated the perspectives of European Melanoma Patient Advocates and collaborators who wanted to discuss their work with the cancer patient community, notably colleagues from iToBoS and MELCAYA, developing AI-based early detection tools in melanoma. The meeting benefited from the contribution of Philippe Page from the Human Colossus Foundation on Data Governance, Johanna Furuhjelm from TEF- Health and Marie-Laure Yaspo from Max Planck Institute for Molecular Genetics  and Alacris Theranostics on Genomic Data.

Our colleagues from  MELCAYA– Lukas Heinlein and David Krauss from the German Cancer Institute presented their work within Work Package 5, Imaging and Machine Learning for Early Diagnosis and Risk Prediction in Pediatric Melanoma, highlighting the challenges of training AI models in rare cancers. Violeta Astratinei from MPNE and Melanoma Romania Association (AMER) introduced and facilitated the session relevant to Work Package 9, which is dedicated to patient engagement in research. The session was an excellent opportunity to collect the views and attitudes of melanoma patients’ advocates on AI and data in the context of melanoma prevention and diagnosis.